Literature DB >> 30244590

Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.

Chun-Qiu Su1, Shan-Shan Lu1, Qiu-Yue Han1, Mao-Dong Zhou1, Xun-Ning Hong1.   

Abstract

BACKGROUND: The application of conventional magnetic resonance imaging (MRI) in glioma grading is limited and non-specific.
PURPOSE: To investigate the application values of MRI, texture analysis (TA) of dynamic contrast-enhanced MRI (DCE-MRI) and intratumoral susceptibility signal (ITSS) on susceptibility weighted imaging (SWI), alone and in combination, for glioma grading.
MATERIAL AND METHODS: Fifty-two patients with pathologically confirmed gliomas who underwent DCE-MRI and SWI were enrolled in this retrospective study. Conventional MRIs were evaluated by the VASARI scoring system. TA of DCE-MRI-derived parameters and the degree of ITSS were compared between low-grade gliomas (LGGs) and high-grade gliomas (HGGs). The diagnostic ability of each parameter and their combination for glioma grading were analyzed.
RESULTS: Significant statistical differences in VASARI features were observed between LGGs and HGGs ( P < 0.05), of which the enhancement quality had the highest area under the curve (AUC) (0.873) with 93.3% sensitivity and 80% specificity. The TA of DCE-MRI derived parameters were significantly different between LGGs and HGGs ( P < 0.05), of which the uniformity of Ktrans had the highest AUC (0.917) with 93.3% sensitivity and 90% specificity. The degree of ITSS was significantly different between LGGs and HGGs ( P < 0.001). The AUC of the ITSS was 0.925 with 93.3% sensitivity and 90% specificity. The best discriminative power was obtained from a combination of enhancement quality, Ktrans- uniformity, and ITSS, resulting in 96.7% sensitivity, 100.0% specificity, and AUC of 0.993.
CONCLUSION: Combining conventional MRI, TA of DCE-MRI, and ITSS on SWI may help to improve the differentiation between LGGs and HGGs.

Entities:  

Keywords:  Glioma; dynamic contrast-enhanced MRI; susceptibility weighted imaging; texture analysis

Mesh:

Substances:

Year:  2018        PMID: 30244590     DOI: 10.1177/0284185118801127

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.

Authors:  Tanhui Chen; Bingqing Jiang; Yingyan Zheng; Dejun She; Hua Zhang; Zhen Xing; Dairong Cao
Journal:  Neuroradiology       Date:  2019-10-31       Impact factor: 2.804

Review 2.  Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Authors:  Domenico Albano; Federico Bruno; Andrea Agostini; Salvatore Alessio Angileri; Massimo Benenati; Giulia Bicchierai; Michaela Cellina; Vito Chianca; Diletta Cozzi; Ginevra Danti; Federica De Muzio; Letizia Di Meglio; Francesco Gentili; Giuliana Giacobbe; Giulia Grazzini; Irene Grazzini; Pasquale Guerriero; Carmelo Messina; Giuseppe Micci; Pierpaolo Palumbo; Maria Paola Rocco; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2021-12-24       Impact factor: 2.374

3.  Quantitative texture analysis based on dynamic contrast enhanced MRI for differential diagnosis between primary thymic lymphoma from thymic carcinoma.

Authors:  Jia-Jia Zhu; Jie Shen; Wei Zhang; Fen Wang; Mei Yuan; Hai Xu; Tong-Fu Yu
Journal:  Sci Rep       Date:  2022-07-24       Impact factor: 4.996

4.  Radiological model based on the standard magnetic resonance sequences for detecting methylguanine methyltransferase methylation in glioma using texture analysis.

Authors:  Wei-Yuan Huang; Ling-Hua Wen; Gang Wu; Pei-Pei Pang; Richard Ogbuji; Chao-Cai Zhang; Feng Chen; Jian-Nong Zhao
Journal:  Cancer Sci       Date:  2021-05-07       Impact factor: 6.716

5.  Texture Analysis in Brain Tumor MR Imaging.

Authors:  Akira Kunimatsu; Koichiro Yasaka; Hiroyuki Akai; Haruto Sugawara; Natsuko Kunimatsu; Osamu Abe
Journal:  Magn Reson Med Sci       Date:  2021-03-10       Impact factor: 2.760

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.